Sedation Safety During Minimally Invasive Heart Valve Procedure
Part of Heart & circulation clinical trials.
This study examines how a specific sedative medication (dexmedetomidine) affects breathing and heart function during a minimally invasive procedure to replace a faulty heart valve. Researchers want to ensure the sedation is safe and effective for older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years or older
- You are scheduled for transfemoral TAVI (a minimally invasive heart valve replacement procedure)
- You will receive sedation (twilight sleep) rather than general anesthesia during the procedure
- You speak French well enough to complete mental clarity tests after the procedure
- You do not have medical conditions that make dexmedetomidine unsafe for you
- Your heart rhythm and blood pressure are stable enough for this procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how well patients recover after a minimally invasive heart valve procedure (TAVR) when given different types of sedation. The goal is to find which sedation approach helps patients feel better and recover faster after the procedure.
This study tests whether adding a second sedative during minimally invasive heart valve surgery can reduce the amount of anesthetic needed, improve recovery, and lower the risk of complications.
This study looks at how a sleep medicine called dexmedetomidine affects thinking and memory after heart surgery. It compares cognitive outcomes over time to see if this sedation choice changes long-term brain function.
This study tests a medicine called remimazolam to see how well it works for sedation (helping you relax and stay comfortable) during a TEE procedure, which is an ultrasound of the heart from the inside. If you are a heart patient having a planned TEE, this trial might help improve your experience.
This trial tests whether a sedating medicine called dexmedetomidine can reduce the risk of “delirium” (sudden confusion) in the intensive care unit after open-heart surgery. If you’re having certain heart operations, it may help protect your thinking and alertness during recovery.
This study compares two sedative medicines to see which one causes less confusion or delirium in older adults after heart valve surgery. Participants will be randomly assigned to receive one of the two medications during their surgery.
Hear when a new TAVI(Transcatheter Aortic Valve Implantation) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.